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Abstract
Several prospective studies have shown an association between cows’ milk consumption and the risk of islet autoimmunity and/or type 1
diabetes. We wanted to study whether processing of milk plays a role. A population-based birth cohort of 6081 children with HLA-DQB1-
conferred risk to type 1 diabetes was followed until the age of 15 years.We included 5545 children in the analyses. Food recordswere completed
at the ages of 3 and 6 months and 1, 2, 3, 4 and 6 years, and diabetes-associated autoantibodies weremeasured at 3–12-month intervals. For milk
products in the food composition database, we used conventional and processing-based classifications.We analysed the data using a jointmodel
for longitudinal and time-to-event data. By the age of 6 years, islet autoimmunity developed in 246 children. Consumption of all cows’ milk
products together (energy-adjusted hazard ratio 1·06; 95 % CI 1·02, 1·11; P= 0·003), non-fermented milk products (1·06; 95 % CI 1·01, 1·10;
P= 0·011) and fermented milk products (1·35; 95 % CI 1·10, 1·67; P= 0·005) was associated with an increased risk of islet autoimmunity.
The early milk consumption was not associated with the risk beyond 6 years. We observed no clear differences based on milk homogenisation
and heat treatment. Our results are consistent with the previous studies, which indicate that highmilk consumptionmay cause islet autoimmunity
in children at increased genetic risk. The study did not identify any specific type of milk processing that would clearly stand out as a sole risk
factor apart from other milk products.
Key words: Children: Milk products: Islet autoimmunity: Homogenisation: Heat treatment: Joint models: Survival analysis
The incidence of type 1 diabetes increased in recent decades
across Europe, although it plateaued after 2005 in Finland,
the incidence rate being 60·9 per 100 000 person-years in
2009–2013(1). Several prospective studies have shown an
association between high consumption of cows’ milk products
and an increased risk of islet autoimmunity and/or type 1
diabetes(2–6), but the findings regarding early cows’milk introduc-
tion are contrasting(7,8).
Abbreviations: DIPP, Type 1 Diabetes Prediction and Prevention; IQR, interquartile range.
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It is unclear which factor(s) in milk, if any, is associated
with the risk of type 1 diabetes. The suspected factors include
bovine insulin(9), milk fat and milk protein(4). The effect of
protein hydrolysation of infant formula has been studied previ-
ously(10,11). Although a strong heat treatment of milk can destroy
the biochemical activity of bovine insulin(12), alter the stability of
protein structures inmilk(13) and change the immune response to
milk in vitro(14), the effect of processing in relation to the devel-
opment of type 1 diabetes has not been studied.
The aim of the present study was to clarify the association
between consumption of differently processed milk products
and the risk of islet autoimmunity by using a Finnish birth cohort
data. Using food records allowed us to use a novel homogenisa-
tion and heat treatment-based classification for milk products.
In Finland, milk consumption per capita is among the highest




Participants of the present study (n 6081) were born between
September 1996 and September 2004 in Oulu and Tampere
University Hospitals in Finland. The Type 1 Diabetes Prediction
and Prevention (DIPP) Nutrition Study is a part of the DIPP
Study which is a prospective, population-based birth cohort
of Finnish children with a high or moderate genetic risk for
type 1 diabetes. The newborn infants’ genotypes for specific
HLA-DQB1 alleles were determined from cord blood. The
high-risk genotype was defined as HLA-DQB1*02/*03:02 and
the moderate-risk genotypes as HLA-DQB1*03:02/x, with x
not equal to *02, *03:01 or *06:02(15). Families with a newborn
infant carrying HLA-conferred susceptibility to type 1 diabetes
were invited to participate in the study. During the follow-up,
growth and antibodies were followed at the ages of 3, 6, 9,
12, 18 and 24months and then annually. If antibodies were
detected, the participants were followed every 3 months. The
blood samples for autoantibody monitoring were collected by
venepuncture up to the age of 15 years.
We included 5545 children in the analyses: the inclusion
criterion was having at least one 3-d food record and at least
one autoantibody measurement after the food record. Among
these 5545 children, the median (interquartile range (IQR)) num-
ber of autoantibody measurements was 14 (IQR 6–18) and 3-d
food records 5 (IQR 3–8) per child. Of the children, 5506 were eli-
gible for the energy-adjusted analyses and 5400 for the breast milk
analyses (online Supplementary Fig. 1). Information on child's sex
and first-degree familial diabetes (any kind) was registered by a
structured questionnaire completed by the parents after delivery.
Ethics
Parents gave their written informed consent for genetic testing
of their newborn infant from the cord blood sample and for par-
ticipation in the follow-up. The study adheres to the Declaration
of Helsinki, and the local ethics committees have approved the
study protocol.
Dietary assessment
The child's diet was assessed at the age of 3 and 6months and 1,
2, 3, 4 and 6 years by a 3-d food record. Collecting and process-
ing of food consumption data have been described in detail
earlier(4). The amount of breast milk was calculated based on
children's growth and intake of other foods(16). If the child
was exclusively breastfed, the calculation was done based on
the growth only. Trained research nutritionists entered the food
record data using the Finnish National Food Composition
Database Fineli and the in-house dietary calculation software
Finessi, the National Institute for Health and Welfare. The food
composition database and the connected dietary calculation
software enabled the calculation of the food intake on an ingre-
dient level(4). Thus, it was possible, for example, to summarise
the total intake of milk from different sources (plain milk and
milk from dishes containing milk). The food consumption data
were used up to the detection of islet autoimmunity or to the
age at the last autoantibody measurement.
Milk product classification
As the conventional grouping for milk products, we used the fol-
lowing: cows’milk products, which consist of the following three
classes: (i) non-fermented milk products which include milks,
creams, ice creams, milk-based infant formulas and powder-like
milk containing preparations; (ii) fermented milk products con-
sisting of fermented milks and sour creams; and (iii) cheeses,
including all kinds of cheeses from fresh cheeses to long-ripened
cheeses. Infant formulas were categorised into two categories:
(i) milk-based formulas including partially hydrolysed formulas;
and (ii) extensively hydrolysed infant formulas.
In the novel processing-based classification, each milk prod-
uct of the food composition database was classified into one of
the following groups based on the homogenisation information:
(1) homogenised, (2) non-homogenised or (3) fat-free; and
into one of the following groups based on the heat treatment
information: (1) low-pasteurised (typically 15 s at 73°C or corre-
sponding conditions where milk alkaline phosphatase is inacti-
vated) or less heat-treated, (2) high-pasteurised at <100°C or
(3) high-pasteurised at ≥100°C or sterilised(17). Products that
included fat not more than 0·5 g/100 g or 0·5 ml/100 ml
were classified as fat-free. Details of the classification and
consumption of different milk products have been described
previously(17). As an example, standard milks were classified
as homogenised or fat-free and low-pasteurised, organic milks
as non-homogenised or fat-free and low-pasteurised, and spe-
cial milks (e.g. lactose-free milks) as homogenised or fat-free
and high-pasteurised at ≥100°C or sterilised. Infant formulas
were classified as homogenised and high-pasteurised at ≥100°
C or sterilised, yogurts as homogenised or fat-free and high-
pasteurised at <100°C, and most ripened cheeses as non-
homogenised and low-pasteurised.
Definition of outcome
As the outcome, we used islet autoimmunity. Islet cell antibodies
were used as the primary testing for islet autoimmunity. If the
child tested positive for islet cell antibodies, all the samples since
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birth were analysed for insulin autoantibodies, antibodies to the
65 kDa isoform of glutamic acid decarboxylase and the tyrosine
phosphatase-related islet antigen2 molecule. The quantification
of the antibody concentrations has been described previ-
ously(18). Islet autoimmunity outcome was defined as repeated
positivity for islet cell antibodies and one or more of the three
biochemical antibodies analysed(19). This outcome also includes
children who developed type 1 diabetes before the islet autoim-
munity outcome (n 34 until the age of 6 years, n 43 until the age
of 15 years). Data of type 1 diabetes diagnosis were obtained
from the national paediatric diabetes registry.
Statistical methods
We used a joint model for longitudinal and time-to-event data
with a current value association structure(20) to analyse the asso-
ciation between consumption of different milk products or
amount of breast milk and the risk of islet autoimmunity. A joint
model consisted of two submodels fitted simultaneously: a linear
mixed effects model for the milk product consumptionmeasure-
ments and a relative risk model for the islet autoimmunity risk.
The linear mixed effects model determined the unobserved milk
product consumption trajectories for the whole time period for
every child, and the covariate trajectories were used in the rela-
tive risk model. The trajectory could be estimated, although
some of the food records were missing. Use of the whole data
in the model reduced the bias related to missing data as all chil-
dren were included in the analyses and the number of the indi-
vidual food records reflected the precision of the estimated
trajectory and in the final standard errors of the estimates. The
trajectories were used in the relative risk model with andwithout
confounding factors until the end point for the particular child
occurred.
We used flexible piecewise cubic polynomial spline func-
tions in the linear mixed effects submodels. At times where con-
sumption was no longer observed, for infant formulas beyond
3 years and for breast milk beyond 2 years, we used values
drawn from a zeromean normal distributionwith negligible vari-
ance tomaintain the trajectory at zero and to improvemodel con-
vergence. For breast milk, we additionally classified the children
into breastfed and not breastfed and added this factor including
the interactions between the spline basis functions to the linear
mixed effects models to obtain better fit of the individual
breast milk trajectories among those with no breast-feeding.
Formulation for the breast milk trajectories is presented in the
online Supplementary Methods. In the relative risk submodels,
time-to-event data were used up to the age of 6 years, which
was the last point of milk product consumption measurements.
The end points that occurred after the age of 6 years were treated
as right-censored at 6 years. Times-to-event for children with
islet autoimmunity were set to the middle of the time interval
between the last islet autoimmunity-negative and the islet
autoimmunity-positive measurement. Otherwise, data were
right-censored at the age of the last autoantibody measurement.
Detailed information on the joint models used has been
described previously(21).
We adjusted the joint models for sex (boy or girl), HLA-
genotype (high ormoderate risk) and diabetes of the first-degree
relative (yes, no or missing value), as these variables have been
previously found to be potential confounders(21). Missing values
in diabetes of the first-degree relative were coded as a third level
of the factor to enable the inclusion of those children in the
model. The energy intake adjustment was done by the density
approach(22) by dividing milk product consumption by total
energy intake (MJ) in every measurement point, and by using
this variable instead of the original absolute consumption in
the models. As milk products were consumed in large amounts,
hazard ratios were scaled to represent relative risk due to
a 20 g/MJ change in the energy-adjusted consumption.
To investigatewhether the association between consumption
of differentmilk products or amount of breast milk and the risk of
islet autoimmunity remains after 6 years of age, until the age of
15 years, we used Cox regression models with the cumulative
consumption of the different milk products as a time-independent
covariate and time origin set at 6 years. Cumulative consumption
was calculated as the area under the curve based on the individual
milk product consumption estimates from the linear mixed effects
model. Data for islet autoimmunity-negative children were right-
censored at the age of the last autoantibody measurement.
Children who experienced the end point by 6 years of age were
excluded from these analyses.
We could not use the joint model for extensively hydrolysed
infant formulas, as they were consumed in small volume and
only by 249 children. For studying the association between
the consumption of extensively hydrolysed infant formulas
and the risk of islet autoimmunity, we dichotomised the variable
based on the information whether the child had consumed
hydrolysed infant formulas (at least in one measurement point)
or not. The association between dichotomised hydrolysed infant
formulas and the risk of islet autoimmunity was analysed with
the Cox regression model.
Analyseswere implementedwith R version 3.4.3 (R Foundation
for Statistical Computing) by using coxph function from the
survival package and jointModel function from the JM package
version 1.4-8(23).
Results
By the age of 6 years, islet autoimmunity developed in
246 children (4·4 %) at median age of 2·5 (IQR 1·3–3·6) years.
In total, by the age of 15 years, islet autoimmunity developed
in 348 children (6·3 %) with median age of 3·5 (IQR 1·8–6·6)
years. The median follow-up time was 6·0 (IQR 3·1–6·0) years
for the 6-year data and 10·0 (IQR 3·1–14·9) for the 15-year data.
The dropout rates at 1, 2, 6 and 15-year follow-up were 8, 16,
32 and 67 %, respectively. Characteristics of the children are
presented in Table 1. The children consumed on an average
slightly less than half a kg of cows’ milk products per d (Table 1).
At all ages, non-fermented milk products were consumed in larger
amounts than fermented milk products (Fig. 1).
Every 100 g increment in consumption of cows’milk products
was associated with a 7 % increase in the risk of islet autoimmun-
ity (Table 2). Both the higher consumption of non-fermented
and fermented milk products were associated with a higher
risk of islet autoimmunity according to the unadjusted and
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energy-adjusted models. We did not observe the association
between the consumption of cheeses or cows’milk-based infant
formulas and the risk of islet autoimmunity. The consumption of
extensively hydrolysed infant formulas was not associated with
the risk (hazard ratio 0·82; 95 % CI 0·44, 1·56; P= 0·558) accord-
ing to the Cox regression model.
Consumption of homogenised milk products was notably
higher than the consumption of non-homogenised milk prod-
ucts at all age points after 3 months and consumption of fat-free
milk products increased by age (Fig. 2). Strongly heat-treated
milk products were consumed more than low-pasteurised ones
during the first year of life, after which low-pasteurised milk
products were consumed more (Fig. 2). The consumption of
homogenisedmilk products was directly associated with the risk
of islet autoimmunity (Table 2), whereas the consumption of
non-homogenised or fat-free milk products was not associated
with the risk. We first analysed separately the two strongest heat
treatment classes, high-pasteurised and sterilised milk products,
but since the hazard ratios were similar, we combined these two
classes. A higher consumption of those milk products was asso-
ciated with a higher risk of islet autoimmunity in the unadjusted
model but not in the adjusted models (Table 2).
Table 1. Characteristics of the participating children























n % n % n % Mean SD Mean SD
Sex
Boys 2950 53·2 148 5·0 212 7·2 572 312 559 286
Girls 2595 46·8 98 3·8 136 5·2 567 292 542 267
HLA-DQB1-conferred risk
High (DQB1*02/*03:02) 1088 19·6 78 7·2 120 11·0 588 295 542 266
Moderate (DQB1*03:02/x)‡ 4457 80·4 168 3·8 228 5·1 565 304 553 280
Familial diabetes
Yes 329 5·9 30 9·1 41 12·5 563 322 536 277
No 5001 90·2 210 4·2 299 6·0 568 302 551 276
Missing information 215 3·9 6 2·8 8 3·7 615 273 576 327
* n of food records= 12 827.
† n of food records= 9766.
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Fig. 1. Consumption of different cows’ milk products at the age of 3months (n 5175), 6 months (n 4838), 1 year (n 4333), 2 years (n 3555), 3 years (n 3330), 4 years
(n 2979) and 6 years (n 2267) using conventional classification. Values are medians, with interquartile ranges represented by vertical bars. Values are calculated based
on all the available data for the 5545 children included in the analyses. The percentages above the lines present the proportion of children using the particular milk product
at that age point.
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The amount of breast milk consumed or energy intake was
not associated with the risk of islet autoimmunity. The Cox
regression model showed that the cumulative amount of cows’
milk products or breast milk up to the age of 6 years was not
associated with the islet autoimmunity risk beyond the age of
6 years (online Supplementary Table 1).
Discussion
In this study, the consumption of cows’milk products was asso-
ciatedwith an increased risk of islet autoimmunity (Table 2). This
result supports previous observations of the possible role of
cows’ milk in the development of type 1 diabetes(2–6).
A major strength of this study is the large, longitudinal food
record data combined with a frequently updated national food
composition database. Using food records instead of FFQ
enabled the use of the milk processing classes, which provide
us a completely novel exposure assessment. Another advantage
of the present study is that we could apply joint model on these
data. Joint models are computationally burdensome, but they
can take intra-individual variation of the food records into
account and are capable of handling incomplete food record
data better than the commonly used Cox regression model(21).
The major limitation of this study is that the milk product clas-
sification is not unambiguous. The type of a milk product is
strongly linked to how it is processed: the milk product type
somewhat determines its processing classification(17). Also, the
children in the present study carry genetic risk for type 1 diabetes
and whether the results can be generalised to the non-risk chil-
dren is unclear. It should also be considered that the dropout
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Fig. 2. Consumption of different cows’ milk products at the age of 3months (n 5175), 6 months (n 4838), 1 year (n 4333), 2 years (n 3555), 3 years (n 3330), 4 years
(n 2979) and 6 years (n 2267) using classification based on (a) homogenisation; (b) heat treatment. Values aremedians, with interquartile ranges represented by vertical
bars. Values are calculated based on all the available data for the 5545 children included in the analyses. The percentages above the lines present the proportion of
children using the particular milk product at that age point.
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methodology permitted the inclusion of all the children in the
analyses, also those who dropped out before the end of their fol-
low-up. As the joint model remains valid under a broad class of
missingness patterns(20), the effect of the dropout rates on the
results should not be substantial.
Considering that the children consumed almost half a kg of
cows’ milk products per d, the risk increment of 7 % per 100 g
of cows’ milk products is notable. In contrast to earlier findings
from a nested case–control study(4) based on parts of the data of
the present one, the present study found that also a higher con-
sumption of fermented milk products was associated with a
higher risk of islet autoimmunity. In the present study, there
are more cases and longer follow-up than in the previous one
and the classification of milk products has been specified(17).
The consumption of infant formulas was not associated with
the islet autoimmunity risk. This is in line with a previous obser-
vation that the amount of cows’ milk consumed at the ages of
3 and 6 months (thus mostly infant formula) was not associated
with the risk of islet autoimmunity(24). However, in that previous
study, infants’ higher cows’ milk consumption was associated
with a higher risk of primary insulin autoimmunity, which
may indicate that risk factors could vary depending on the
type of islet autoimmunity. Due to the uses of infant formulas,
consumption of strongly heated milk products is high in the
first months of life (Fig. 2). However, the consumption of
high-pasteurised or sterilised milk products was associated with
an increased islet autoimmunity risk in the unadjusted model,
unlike infant formulas. The composition of infant formula differs
from standardmilk – they, for example, containmore lactose and
less protein than milk, and the protein fractions are modified.
They also have different fat composition with generally added
vegetable oils.
Consumption of homogenised milk products was directly
associated with the islet autoimmunity risk. The consump-
tion of non-homogenised milk products showed similar but
non-significant hazard ratios. Stratification of the milk consump-
tion according to milk processing (Fig. 2) apparently reduced
the number of individuals using less commonly consumed
food items, which could have compromised statistical power
in those comparisons, such as non-homogenised milk products.
Therefore, the lack of associations in these should not be consid-
ered conclusive. On the other hand, in this study, consumption
of fat-free milk products showed no association with the risk of
islet autoimmunity, while milk fat has been associated with an
increased islet autoimmunity risk previously(4). Altogether, these
results indicate that expression of fat in milk may contribute its
possible diabetogenic properties. During homogenisation, milk
fat globules are broken into smaller particles using pressure.
The milk fat globule membrane cannot cover the new droplets
completely, and mainly casein micelles are adsorbed on the fat
globule surface(25). Also, homogenisation has been shown to
reduce the concentration of native proteins in milk(26). In rats,
it has been observed that exposure to homogenised milk is
associated with higher concentrations of milk protein antibod-
ies comparedwith non-homogenised milk suggesting different
immunisation responses(27), but in humans evidence is lacking.
Several studies have reported a protective association
between total or exclusive breast-feeding and the risk of type
1 diabetes(8). We did not see this association in the present
study. Previously high intake of breast milk has been associ-
ated with a decreased risk for primary insulin autoimmunity
only(24).
The cumulative consumption of milk products up to the age
of 6 years was not associated with the islet autoimmunity devel-
opment after the age of 6 years, even though there was a direct
association between milk product consumption and the islet
autoimmunity risk until the age of 6 years. This indicates that a
continuous trigger is needed for the islet autoimmunity to
develop, rather than that there would be programming by early
milk product consumption.
Table 2. Risk of islet autoimmunity (cases n 246, total n 5545) by the age of 6 years associated with breast milk and consumption of different types of milk
products based on the basic joint model
(Hazard ratios (HR) and 95% confidence intervals)
Unadjusted model* Adjusted model*† Energy-adjusted model‡
HR 95% CI P HR 95% CI P HR 95% CI P
Amount of breast milk§ 0·96 0·87, 1·05 0·328 0·96 0·87, 1·05 0·357 0·96 0·90, 1·01 0·130
Conventional classification
Cows’ milk products 1·07 1·01, 1·14 0·019 1·06 1·00, 1·13 0·037 1·06 1·02, 1·11 0·003
Non-fermented milk products 1·06 1·00, 1·13 0·045 1·06 1·00, 1·12 0·071 1·06 1·01, 1·10 0·011
Milk-based infant formulas|| 1·04 0·89, 1·20 0·645 1·02 0·88, 1·19 0·767 1·01 0·89, 1·14 0·866
Fermented milk products¶ 1·33 1·05, 1·70 0·018 1·29 1·02, 1·65 0·038 1·35 1·10, 1·67 0·005
Cheeses 1·62 0·32, 8·33 0·561 1·57 0·30, 8·23 0·594 1·67 0·29, 9·80 0·568
Processing-based classification
Homogenisation
Homogenised milk products 1·08 1·02, 1·15 0·007 1·08 1·02, 1·14 0·010 1·07 1·03, 1·12 <0·001
Non-homogenised milk products 1·08 0·93, 1·26 0·327 1·08 0·93, 1·27 0·324 1·06 0·93, 1·22 0·395
Fat-free milk products 0·97 0·87, 1·07 0·482 0·96 0·87, 1·06 0·408 0·97 0·87, 1·07 0·494
Heat treatment
Low-pasteurised or less heat-treated milk products 1·03 0·96, 1·11 0·392 1·03 0·96, 1·11 0·398 1·04 0·98, 1·11 0·210
High-pasteurised or sterilised milk products 1·07 1·00, 1·15 0·044 1·06 0·99, 1·14 0·084 1·04 0·99, 1·09 0·105
* HR and CI are presented per consumption of 100 g of food item.
† Adjusted for child's sex, genetic risk and first-degree familial diabetes.
‡ HR and CI are presented per consumption of 20 g/MJ of food item.
§ For breast milk analysis, cases n 240, total n 5400.
|| Does not include extensively hydrolysed formulas.
¶ Does not include cheeses. Cheeses are presented separately.
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This study adds new information on top of the previous evi-
dence on the association between high cows’milk consumption
and development of type 1 diabetes. However, as the findings
regarding early cows’ milk consumption are contrasting, more
studies in different study settings should be conducted before
changes in nutritional recommendations should be made.
As nutrition recommendations are most likely best transferred
to the public when they are coherent and enough generic, creat-
ing unnecessary restrictions should be avoided. Nationwide,
milk and milk products are an important source of several
nutrients, for example, Ca, vitamin D, vitamin B12 and iodine(28).
Future research should also target identifying the possible com-
ponents in cows’ milk responsible for the associations.
In conclusion, the results of this study are parallel with several
previous findings confirming the association between high con-
sumption of cows’milk products and increased risk of islet auto-
immunity. The early milk consumption was no longer associated
with increased risk of islet autoimmunity onset beyond 6 years.
The study did not identify any specific type of milk processing
that would clearly stand out as a sole risk factor apart from
other milk products. However, the study implicates that future
research focusing on the possible association between food
consumption and type 1 diabetes should also consider food
processing.
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